|Slideshows|June 16, 2017

ADA 2017 Hypoglycemia and role glycemic variability

Among studies presented at at the ADA 77thÂ Scientific Sessions were evaluations of hypoglycemia incidence in large populations, the relation of glycemic variability to risk of hypoglycemia, and glycemic variability as an alternative method to predict hypoglycemia.Three stuides are summarized in the slides above; links to abstracts are provided in the captions.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

ADA 2017 Hypoglycemia and role glycemic variability

Related Content

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

New sunscreen ingredient clears FDA for the first time since the 1990s

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy